Novel 5-Hydroxytryptamine (5-HT3) Receptor Antagonists. Part 3. Pharmacological Evaluations and Molecular Modeling Studies of Optically Active 4,5,6,7-Tetrahydro-1H-benzimidazole Derivatives.